Tiered Screening of Therapeutic TCRs for Identification of Autoimmune Cross-Reactivity
Summary:
The National Cancer Institute seeks research co-development partners and/or licensees for a standardized method of detecting T-cell receptor (TCR) cross-reactivity as a means of proving safety and efficacy in preclinical evaluations ahead of clinical trials.
Description of Technology: